Massive Growth of Contrast Media Agents Market Size, Comprehensive Analysis, Opportunities and Precise Outlook by 2025 Profiling Bayer AG, Bracco, GUERBET , Jodas Expoim and others

Growth Opportunities in The Developing Nations:-

The number of chronic non-communicable disease are rising across the globe, the prevalence is significantly rising among the developing nations across the globe. The incidences are rising due to the shift in the lifestyle and the other health conditions sue to the change in the adoption of the modernized facilities.

The modernized facilities reduced the physical activities, the stress level among the people are also rising. This is expected to be a leading factor to support rising demand for the contrast media agents, with generating patient awareness regarding taking preventive measures as well as benefits of early diagnosis.

Get Sample Copy of the Report at - http://cutt.us/GDoRd

The developing nations are significantly developing their healthcare facilities and services and are heading towards the technological advancements. With increasing costs of manufacturing against their practices, the medical device manufacturers are struggling to generate enough revenue to please their investors. The emerging markets in the developing economies are expected to be the crucial factor offering better and lucrative growth opportunities for the major players to expand their business and geographic reach.

Profiling Leading Key Vendors are:

- General Electric
- Bayer AG
- Bracco
- GUERBET
- Lantheus Medical Imaging, Inc.
- nanoPET Pharma GmbH
- Unijules Life Sciences Ltd.
- Magnus Health Management Pvt Ltd.
- J.B.Chemicals and Pharmaceuticals Ltd.
- Jodas Expoim

The global contrast media agents market accounted to US$ 4,855.2 Mn in 2018 and is expected to grow at a CAGR of 4.0% during the forecast period 2019 – 2027, to account to US$ 6,860.6 Mn by 2027.

Medical imaging has become essential to medical care and treatment across the globe. Rising awareness regarding early diagnosis of diseases have led to increase in the total number of diagnostic tests procedures performed across the globe. In 2012, Canadians underwent 1.7 million magnetic resonance imaging (MRI) exams and 4.4 million computed tomography (CT) exams.

This represents nearly double the number of such exams performed in 2003. In 2014-15, the national rate for CT scans was 126 per 1,000 people. Rates ranged from highs of 209 (New Brunswick) and 170 (Newfoundland and Labrador) to lows of 88 (Alberta) and 93 (Prince Edward Island). Moreover, according to the National Health Services (NHS) UK, there were 4.1 million imaging tests reported in England in the 12 months from February 2016 to January 2017. Of these, 3.49 million imaging tests were reported to have taken place in January 2017.

Asia Pacific is the fastest growing geographic market and it is expected to be the fastest revenue contributor throughout the forecast period. Asia Pacific is recognized as a developing market for the medical devices. The growth is driven by the factors such as increase in the developments for the healthcare industry and infrastructure, increasing consolidation by market players for the development of the diagnostic systems, reforming budgets of the diagnostic imaging technologies and rising medical tourism in the region.

Get Discount on the Report at - http://cutt.us/1HVgk

Contrast Media Agents – MARKET SEGMENTATION

By Type

• Iodinated Contrast Media
• Gadolinium Based Contrast Media
• Barium Based Contrast Media
• Microbubble Contrast Media

By Imaging Modality

• X-Ray/CT
• Magnetic Resonance Imaging
• Ultrasound

By Indication

• Cardiovascular Disorders
• Cancer
• Gastrointestinal Disorders
• Musculoskeletal Disorders
• Neurological Disorders
• Nephrological Disorders

By Route of Administration

• Intravascular
• Oral
• Rectal

Strategic Insights

Organic and inorganic growth strategies were observed in global contrast media agents industry. For instance, in April, 2019, Lantheus Medical Imaging, Inc. entered into a strategic collaboration with Cerevast Medical, Inc. identify new applications for its microbubble franchise and expand into new disease areas, such as ocular diseases. Thus, the inorganic strategy has enabled the company to grow its business in the market.

End User Insights

The global contrast media agents market by route of administration segments was led by intravascular segment. In 2018, the intravascular held a largest market share of 80.3% of the contrast media agents market, by route of administration. This segment is also expected to be the fastest growing segments of the market in 2027 owing to wide use of the contrast media injection and its advantages of delivering injection at any part of the body which is becoming the major factor for the growth of the contrast media agents market.

Purchase this Report at - http://cutt.us/JrxJg

Reason to Buy this Report:

- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Global Contrast Media Agents Market.

- Highlights key business priorities in order to assist companies to realign their business strategies.

- The key findings and recommendations highlight crucial progressive industry trends in the Contrast Media Agents, thereby allowing players to develop effective long term strategies.

- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to products, segmentation and industry verticals.

Contact Us:
Call: +1-646-491-9876
Email: sales@theinsightpartners.com
Website: www.theinsightpartners.com/

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.

This release was published on openPR.